151 related articles for article (PubMed ID: 15158773)
1. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
Nimrichter L; Barreto-Bergter E; Mendonça-Filho RR; Kneipp LF; Mazzi MT; Salve P; Farias SE; Wait R; Alviano CS; Rodrigues ML
Microbes Infect; 2004 Jun; 6(7):657-65. PubMed ID: 15158773
[TBL] [Abstract][Full Text] [Related]
2. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.
Alviano DS; Franzen AJ; Travassos LR; Holandino C; Rozental S; Ejzemberg R; Alviano CS; Rodrigues ML
Infect Immun; 2004 Jan; 72(1):229-37. PubMed ID: 14688100
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions.
Rollin-Pinheiro R; Liporagi-Lopes LC; de Meirelles JV; Souza LM; Barreto-Bergter E
PLoS One; 2014; 9(5):e98149. PubMed ID: 24878570
[TBL] [Abstract][Full Text] [Related]
4. Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.
Nimrichter L; Cerqueira MD; Leitão EA; Miranda K; Nakayasu ES; Almeida SR; Almeida IC; Alviano CS; Barreto-Bergter E; Rodrigues ML
Infect Immun; 2005 Dec; 73(12):7860-8. PubMed ID: 16299276
[TBL] [Abstract][Full Text] [Related]
5. Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis.
Hayakawa M; Ghosn EE; da Gloria Teixeria de Sousa M; Ferreira KS; Almeida SR
Scand J Immunol; 2006 Oct; 64(4):382-7. PubMed ID: 16970678
[TBL] [Abstract][Full Text] [Related]
6. Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.
Dong B; Tong Z; Li R; Chen SC; Liu W; Liu W; Chen Y; Zhang X; Duan Y; Li D; Chen L
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006237. PubMed ID: 29481557
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.
Bocca AL; Brito PP; Figueiredo F; Tosta CE
Mycopathologia; 2006 Apr; 161(4):195-203. PubMed ID: 16552481
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression.
da Silva JP; da Silva MB; Salgado UI; Diniz JA; Rozental S; Salgado CG
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):104-11. PubMed ID: 17451443
[TBL] [Abstract][Full Text] [Related]
9. Glucosylceramides From
Xisto MIDDS; Henao JEM; Dias LDS; Santos GMP; Calixto ROR; Bernardino MC; Taborda CP; Barreto-Bergter E
Front Microbiol; 2019; 10():554. PubMed ID: 30967849
[No Abstract] [Full Text] [Related]
10. Local phagocytic responses after murine infection with different forms of Fonsecaea pedrosoi and sclerotic bodies originating from an inoculum of conidiogenous cells.
Machado AP; Silva MR; Fischman O
Mycoses; 2011 May; 54(3):202-11. PubMed ID: 19925569
[TBL] [Abstract][Full Text] [Related]
11. A chitin-like component on sclerotic cells of Fonsecaea pedrosoi inhibits Dectin-1-mediated murine Th17 development by masking β-glucans.
Dong B; Li D; Li R; Chen SC; Liu W; Liu W; Chen L; Chen Y; Zhang X; Tong Z; Xia Y; Xia P; Wang Y; Duan Y
PLoS One; 2014; 9(12):e114113. PubMed ID: 25490199
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor.
Alviano DS; Kneipp LF; Lopes AH; Travassos LR; Meyer-Fernandes JR; Rodrigues ML; Alviano CS
Res Microbiol; 2003 Dec; 154(10):689-95. PubMed ID: 14643407
[TBL] [Abstract][Full Text] [Related]
13. Glucosylceramides in Colletotrichum gloeosporioides are involved in the differentiation of conidia into mycelial cells.
da Silva AF; Rodrigues ML; Farias SE; Almeida IC; Pinto MR; Barreto-Bergter E
FEBS Lett; 2004 Mar; 561(1-3):137-43. PubMed ID: 15013765
[TBL] [Abstract][Full Text] [Related]
14. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
Vidal MS; de Castro LG; Cavalecate SC; Lacaz Cda S
Rev Inst Med Trop Sao Paulo; 2003; 45(6):315-8. PubMed ID: 14762630
[TBL] [Abstract][Full Text] [Related]
15. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
[TBL] [Abstract][Full Text] [Related]
16.
Breda LCD; Breda CNS; de Almeida JRF; Paulo LNM; Jannuzzi GP; Menezes IG; Albuquerque RC; Câmara NOS; Ferreira KS; de Almeida SR
Front Immunol; 2020; 11():540064. PubMed ID: 33193308
[TBL] [Abstract][Full Text] [Related]
17. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures.
Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):21-9. PubMed ID: 16420593
[TBL] [Abstract][Full Text] [Related]
18. Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis.
Sotto MN; De Brito T; Silva AM; Vidal M; Castro LG
J Cutan Pathol; 2004 Jan; 31(1):14-8. PubMed ID: 14675280
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of glucosylceramides (GlcCer) from species of the Pseudallescheria/Scedosporium complex.
Calixto RO; Rollin-Pinheiro R; da Silva MI; Liporagi-Lopes LC; Vieira JM; Sassaki GL; Barreto-Bergter E
Fungal Biol; 2016 Feb; 120(2):166-72. PubMed ID: 26781373
[TBL] [Abstract][Full Text] [Related]
20. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi.
Vidal MS; Castro LG; Cavalcante SC; Lacaz CS
Med Mycol; 2004 Dec; 42(6):511-5. PubMed ID: 15682639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
